Patents by Inventor Tim Dargaville

Tim Dargaville has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230365754
    Abstract: The present invention relates to combinations of a poly(2-oxazoline) or poly(2-oxazine)5 polymer or copolymer having an allylamido side chain and a cross-linker, cross-linked compositions thereby obtained and hydrogels thereof. Further, the present invention discloses methods of providing the combination, compositions and hydrogels described herein and their use.
    Type: Application
    Filed: October 19, 2021
    Publication date: November 16, 2023
    Inventors: Richard HOOGENBOOM, Tim DARGAVILLE
  • Patent number: 11730696
    Abstract: The present invention relates to the use of scaffolds to enhance the viability of cells implanted in the integumentary system such that the cell may release an agent. The scaffold is capable of protecting the cell, as well as allowing for adequate nutrient delivery at the implant site through vascularisation in and around the scaffold.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: August 22, 2023
    Assignee: AUSTRALIAN FOUNDATION FOR DIABETES RESEARCH
    Inventors: Bernard Tuch, Tim Dargaville, Auvro Mridha, Paul Dalton, Vijayaganapathy Vaithilingam
  • Publication number: 20190254959
    Abstract: The present invention relates to the use of scaffolds to enhance the viability of cells implanted in the integumentary system such that the cell may release an agent. The scaffold is capable of protecting the cell, as well as allowing for adequate nutrient delivery at the implant site through vascularisation in and around the scaffold.
    Type: Application
    Filed: October 18, 2017
    Publication date: August 22, 2019
    Inventors: Bernard Tuch, Tim Dargaville, Auvro Mridha, Paul Dalton, Vijayaganapathy Vaithilingam
  • Patent number: 8747830
    Abstract: The invention provides a dressing composition comprising a bisphosphonate matrix metalloproteinase (MMP) inhibitor covalently bound to a polymer wherein, when the dressing is contacted with a wound, substantially all of the bisphosphonate remains with the dressing composition and is unable to enter the wound tissue. The invention also provides for a method of treatment of a wound by contacting a dressing composition comprising a covalently bound MMP inhibitor with the wound fluid to thereby selectively inhibit one or more MMP's in the wound fluid without inhibiting those in the wound tissue.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: June 10, 2014
    Assignee: Queensland University of Technology
    Inventors: Erin A. Rayment, Tim Dargaville, Zee Upton
  • Publication number: 20100172860
    Abstract: The invention provides a dressing composition comprising a bisphosphonate matrix metalloproteinase (MMP) inhibitor covalently bound to a polymer wherein, when the dressing is contacted with a wound, substantially all of the bisphosphonate remains with the dressing composition and is unable to enter the wound tissue. The invention also provides for a method of treatment of a wound by contacting a dressing composition comprising a covalently bound MMP inhibitor with the wound fluid to thereby selectively inhibit one or more MMP's in the wound fluid without inhibiting those in the wound tissue.
    Type: Application
    Filed: June 10, 2008
    Publication date: July 8, 2010
    Applicant: QUEENSLAND UNIVERSITY OF TECHNOLOGY
    Inventors: Erin A. Rayment, Tim Dargaville, Zee Upton